Journey Medical Corporation announced impairment charges for the second quarter ended June 30, 2023. For the quarter, the company reported loss on impairment of intangible assets of $3,143,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.57 USD | +1.71% | +0.56% | -38.02% |
05-13 | Transcript : Journey Medical Corporation, Q1 2024 Earnings Call, May 13, 2024 | |
05-13 | Journey Medical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.02% | 71.3M | |
+29.98% | 682B | |
+30.93% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.77% | 240B | |
+9.85% | 209B | |
-8.43% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- DERM Stock
- News Journey Medical Corporation
- Journey Medical Corporation Announces Impairment Charges for the Second Quarter Ended June 30, 2023